A peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice.
A peptide derived from activity-dependent neuroprotective protein (ADNP) ameliorates injury response in closed head injury in mice.
复制标题
DOI:
--
复制
发表时间:
2001
期刊:
影响因子:
--
通讯作者:
L. Beni‐Adani;I. Gozes;Y. Cohen;Y. Assaf;R. Steingart;D. Brenneman;O. Eizenberg;V. Trembolver;E. Shohami
中科院分区:
文献类型:
--
作者:
L. Beni‐Adani;I. Gozes;Y. Cohen;Y. Assaf;R. Steingart;D. Brenneman;O. Eizenberg;V. Trembolver;E. Shohami
Brain injury induces disruption of the blood-brain barrier, edema, and release of autodestructive factors that produce delayed neuronal damage. NAPSVIPQ (NAP), a femtomolar-acting peptide, is shown to be neuroprotective in a mouse model of closed head injury. NAP injection after injury reduced mortality and facilitated neurobehavioral recovery (P < 0.005). Edema was reduced by 70% in the NAP-treated mice (P < 0.01). Furthermore, in vivo magnetic resonance imaging demonstrated significant brain-tissue recovery in the NAP-treated animals. NAP treatment decreased tumor necrosis factor-alpha levels in the injured brain and was shown to protect pheochromocytoma (PC12 cells) against tumor necrosis factor-alpha-induced toxicity. Thus, NAP provides significant amelioration from the complex array of injuries elicited by head trauma.